benzohydroxamic acid has been researched along with 4-((1-butyl-3-phenylureido)methyl)-n-hydroxybenzamide in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Caprini, G; Cellupica, E; Cordella, P; Fossati, G; Galbiati, E; Lattanzio, M; Leoni, F; Marchini, M; Modena, D; Pagani, P; Pavich, G; Perego, R; Pezzuto, M; Pomarico, R; Porro, G; Pozzi, P; Ripamonti, C; Rocchio, I; Sandrone, G; Skorupska, M; Steinkühler, C; Stevenazzi, A; Vergani, B | 1 |
1 other study(ies) available for benzohydroxamic acid and 4-((1-butyl-3-phenylureido)methyl)-n-hydroxybenzamide
| Article | Year |
|---|---|
Novel Benzohydroxamate-Based Potent and Selective Histone Deacetylase 6 (HDAC6) Inhibitors Bearing a Pentaheterocyclic Scaffold: Design, Synthesis, and Biological Evaluation.
Topics: Animals; Cell Survival; Drug Design; Gene Expression Regulation, Enzymologic; Histone Deacetylase 6; Histones; Hydroxamic Acids; Mice; Protein Isoforms; Spleen; T-Lymphocytes, Regulatory; Tubulin | 2019 |